Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 131

1.

Vaso-occlusive crisis episodes in sickle cell disease.

Adhikary PK, Hara S, Dwivedi C, Davis JW, Weaver C, Pavuluri SR.

J Med. 1986;17(3-4):227-40.

PMID:
3473166
2.

Primary hyperparathyroidism mimicking vaso-occlusive crises in sickle cell disease.

Krishnamoorthy P, Alyaarubi S, Abish S, Gale M, Albuquerque P, Jabado N.

Pediatrics. 2006 Aug;118(2):e537-9.

PMID:
16882790
3.

Plasma fibrinogen levels in sickle cell disease.

Famodu AA, Reid HL.

Trop Geogr Med. 1987 Jan;39(1):36-8.

PMID:
3603689
4.

Hyperfibrinogenaemia and hyperviscosity in sickle-cell crisis.

Richardson SG, Breeze GR, Stuart J.

J Clin Pathol. 1976 Oct;29(10):890-3.

5.

Effect of low-dose warfarin on D-dimer levels during sickle cell vaso-occlusive crisis: a brief report.

Ahmed S, Siddiqui AK, Iqbal U, Sison CP, Shahid RK, Sheth M, Patel DV, Russo LA.

Eur J Haematol. 2004 Mar;72(3):213-6.

PMID:
14962240
6.

Hydroxyurea and sickle cell anemia. Clinical utility of a myelosuppressive "switching" agent. The Multicenter Study of Hydroxyurea in Sickle Cell Anemia.

Charache S, Barton FB, Moore RD, Terrin ML, Steinberg MH, Dover GJ, Ballas SK, McMahon RP, Castro O, Orringer EP.

Medicine (Baltimore). 1996 Nov;75(6):300-26.

8.

Serum ferritin concentration in sickle cell crisis.

Brownell A, Lowson S, Brozović M.

J Clin Pathol. 1986 Mar;39(3):253-5.

9.

Cytokine profile of sickle cell disease in Oman.

Pathare A, Al Kindi S, Alnaqdy AA, Daar S, Knox-Macaulay H, Dennison D.

Am J Hematol. 2004 Dec;77(4):323-8.

10.

Erythrocyte deformability in sickle-cell crisis.

Kenny MW, Meakin M, Worthington DJ, Stuart J.

Br J Haematol. 1981 Sep;49(1):103-9.

PMID:
7272221
11.

Oxygen delivery index in homozygous sickle cell disease: steady and crisis states.

Bowers AS, Pepple DJ, Reid HL.

Br J Biomed Sci. 2009;66(3):148-9.

PMID:
19839226
12.

Plasma fibrinolytic activity in sickle cell disease.

Famodu AA.

Trop Geogr Med. 1988 Oct;40(4):331-3.

PMID:
3227553
13.

Fragment D-dimer levels: an objective marker of vaso-occlusive crisis and other complications of sickle cell disease.

Devine DV, Kinney TR, Thomas PF, Rosse WF, Greenberg CS.

Blood. 1986 Jul;68(1):317-9.

14.

Hepatic function tests in children with sickle cell anaemia during vaso occlusive crisis.

Ojuawo A, Adedoyin MA, Fagbule D.

Cent Afr J Med. 1994 Dec;40(12):342-5.

PMID:
7882414
15.

Plasma endothelin-1, cytokine, and prostaglandin E2 levels in sickle cell disease and acute vaso-occlusive sickle crisis.

Graido-Gonzalez E, Doherty JC, Bergreen EW, Organ G, Telfer M, McMillen MA.

Blood. 1998 Oct 1;92(7):2551-5.

16.

Cardiorespiratory adjustments in chronic sickle cell anemia.

Lonsdorfer J, Bogui P, Otayeck A, Bursaux E, Poyart C, Cabannes R.

Bull Eur Physiopathol Respir. 1983 Jul-Aug;19(4):339-44.

PMID:
6626765
17.

Using serial haemorheological parameters to assess clinical status in sickle cell anaemia patients in vaso-occlussive crisis.

Awodu OA, Famodu AA, Ajayi OI, Enosolease ME, Olufemi OY, Olayemi E.

Clin Hemorheol Microcirc. 2009;41(2):143-8. doi: 10.3233/CH-2009-1167.

PMID:
19252237
18.

Significance of platelet activation in sickle cell anaemia.

Ibanga IA.

Niger J Med. 2006 Apr-Jun;15(2):148-50.

PMID:
16805172
19.

Vasoactive factors in sickle cell disease: in vitro evidence for endothelin-1-mediated vasoconstriction.

Ergul S, Brunson CY, Hutchinson J, Tawfik A, Kutlar A, Webb RC, Ergul A.

Am J Hematol. 2004 Jul;76(3):245-51.

20.

Supplemental Content

Support Center